BNRG Brenmiller Energy Ltd.
Price Chart
Executive Summary
Brenmiller Energy entered into Amendment No. 2 to its Securities Purchase Agreement with Alpha Capital Anstalt, securing an immediate $1.5 million investment through convertible preferred shares (initial conversion price $1.67, subject to increase to $2.00 upon shareholder approval) and warrants. The deal also provides for up to an additional $1.0 million from warrant exercises contingent on shareholder approval and a $1.30 share-price condition. Net proceeds will fund general corporate purposes, working capital, and commercial TES projects.
Actionable Insight
The $1.5 million injection provides near-term liquidity for a micro-cap company, but the structure is highly dilutive (preferred shares convertible at $1.67, plus up to 1,075,000 new warrants at $2.00). Monitor the shareholder vote in ~2 weeks — approval unlocks the conversion price increase to $2.00 and warrant repricing, which reduces immediate dilution risk but also enables the additional $1.0 million exercise. The $1.30 price condition for short-term warrant exercise is a key catalyst; if BNRG stays above $1.30, expect accelerated dilution. The cross-filing 20-F (annual report) provides context on the company's financial position and ongoing reliance on this funding source.
Key Facts
- Immediate $1.5 million investment via convertible preferred shares with initial conversion price of $1.67 per share.
- Conversion price may increase to $2.00 per share subject to shareholder approval.
- Company to issue pre-funded warrant for 75,000 shares, short-term warrants for 500,000 shares (expiring 1 week post-approval), and 5-year warrants for 500,000 shares, all at $2.00 exercise price, subject to shareholder approval.
- Alpha Capital agrees to exercise short-term warrants if 5-day VWAP before approval is at least $1.30, potentially adding $1.0 million.
- Shareholder meeting proxy must be filed within 14 days; Alpha Capital agrees to vote in favor.
- Exercise price of 1,700,000 existing warrants held by Alpha Capital reduced to $2.00 per share, effective upon shareholder approval.
- Net proceeds to be used for general corporate purposes, working capital, and commercial TES projects in Europe, U.S., and Middle East.
- Company has a market cap of approximately $3 million.
Financial Impact
Immediate $1.5 million preferred share investment, with potential additional $1.0 million from warrant exercises, totaling up to $2.5 million. Existing warrants on 1,700,000 shares repriced to $2.00.
Risk Factors
- Massive dilution from conversion of preferred shares and exercise of up to 1,075,000 new warrants at $2.00, plus repricing of 1,700,000 existing warrants to $2.00.
- Shareholder approval is required for key terms — failure to obtain approval could trigger adverse adjustments or renegotiation.
- The $1.30 price condition for short-term warrant exercise creates a binary event; if the stock trades below $1.30, the additional $1.0 million may not materialize.
- Company has a $3M market cap and is pre-revenue or early-stage — reliance on this single investor for capital is a concentration risk.
- Nasdaq continued listing standards may be at risk given the low market cap and repeated dilutive financings.
Market Snapshot
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-067568 |
| Document: ea0294397-6k_brenmiller.htm | 0001213900-26-067568 |
| Document: ea029439701ex10-2.htm | 0001213900-26-067568 |
| Document: ea029439701ex99-1.htm | 0001213900-26-067568 |
| Document: 0001213900-26-067568-index-headers.html | 0001213900-26-067568 |
| Document: 0001213900-26-067568-index.html | 0001213900-26-067568 |
| Document: 0001213900-26-067568.txt | 0001213900-26-067568 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 15, 2026
today
|
EFFECT
| — | awaiting T+1 | — | — |
|
Jun 11, 2026
3d ago
|
6-K
| $1.32 awaiting T+1 | awaiting T+1 | — | $1.22 (−7.58%) |
|
Jun 2, 2026
12d ago
|
6-K
| $1.35 $1.82 | ▼ −34.81% | ▼ −35.51% | $1.22 (+9.63%) |
|
May 18, 2026
28d ago
|
EFFECT
| $1.72 $1.57 | ▲ +8.72% | ▲ +8.07% | $1.22 (+29.07%) |
|
Apr 27, 2026
6w ago
|
6-K
| $3.06 $2.80 | ▲ +8.66% | ▲ +8.65% | $1.22 (+60.13%) |
|
Mar 31, 2026
10w ago
|
6-K
| $3.02 $3.17 | ▲ +5.14% | ▲ +4.39% | $1.22 (−59.54%) |
|
Mar 23, 2026
12w ago
|
EFFECT
| $3.38 $3.45 | ▲ +2.07% | ▲ +2.43% | $1.22 (−63.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access